Nicotine Polacrilex Lozenge
Product Images NDC 71335-2729

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 71335-2729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (713352729 E Label)

Extended Label (713352729 E Label)
A text panel providing usage guidelines for Nicotine Polacrilex 2 mg lozenges, including precautions for users under 18, instructions to read the User's Guide, and recommended dosing schedules based on the time to the first cigarette after waking. The panel includes a 12-week dosing schedule table with dosing frequency recommendations for weeks 1 to 12.*
FDA Label Image

Wallet Card Image 1 (Image 01)

Wallet Card Image 1 (Image 01)
A wallet card titled 'My most important reasons to quit smoking are:' with five blank lines for writing reasons. The card is designed as a motivational aid to support smoking cessation efforts.*
FDA Label Image

Wallet Card Image 2 (Image 02)

Wallet Card Image 2 (Image 02)
A wallet card illustration providing contact information for quitting assistance. It lists phone numbers for the American Lung Association, American Cancer Society, and American Heart Association. The card also mentions having a quitting buddy or friend who has quit for support.*
FDA Label Image

Smoke Free Habits Logo (Image 03)

FDA Label Image

Upc Example (Image 04)

FDA Label Image

Reminder Stickers (Image 05)

Reminder Stickers (Image 05)
An instructional diagram showing a four-step reminder schedule for using Nicotine Polacrilex lozenges. Step 1 (red) advises 1 lozenge every 1 to 2 hours at the beginning of week 1 (quit date). Step 2 (blue) advises 1 lozenge every 2 to 4 hours at the beginning of week 7. Step 3 (black) advises 1 lozenge every 4 to 8 hours at the beginning of week 10. The final green box labeled EX-SMOKER refers to 12 weeks after the quit date.*
FDA Label Image

Label (Lbl713352729)

Label (Lbl713352729)
Drug Facts panel for Nicotine Polacrilex lozenge 2 mg, showing active ingredient, purpose, uses, warnings, other information, directions, and inactive ingredients. Also includes product name, strength, quantity (81 lozenges, 3 mini QuitTube of 27), labeler (Bryant Ranch Prepack, Inc.), and barcode with NDC 71335-2729-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.